CBD OIL FOR ANIMALS

Cannabidiol or CBD for short is a plant substance from cannabis that is used in cosmetics, food and medicine and has no psychotropic properties. Cannabis is one of the oldest useful plants and has accompanied mankind for many thousands of years.

CBD cannabis is increasingly becoming the focus of research, medicine and the media. According to the World Health Organisation (WHO), the following properties have been scientifically investigated:

• Analgesic
• Anti-inflammatory
• Anxiety relieving and antidepressant
• Uncluttering
• Nerve Protective
• Antioxidant
• Antipsychotic

Source: World Health Organisation (2018). Cannabidiol (CBD) Critical Review Report. Expert Committee on Drug Dependence. Fortieth Meeting. Geneva, 4-7 June 2018

For humans, there are a large number of products based on whole extract, which are not tolerated by pets such as cats. Our CANNEXOLCBD products for pets are specially developed for the respective requirements of the animals. Dogs, cats and horses, like humans, have a natural endocannabinoid system. Therefore, animals can also benefit from the effect of CBD. In our blog you can find more information about dogs, cats and horses.

Cats also have an endocannabinoid system and can therefore benefit from CBD. However, as cats do not tolerate THC & terpenes, our CANNEXOL Cat 3% CB D consists of certified organic sunflower oil and high-quality CBD extract. This is why it is completely safe for cats to use.

cannhelpstands for a quality-oriented approach to natural products, with the aim of enabling all people to lead a healthy and self-determined life. Our transparency regarding production and ingredients, combined with our many years of experience in the production of affordable CBD products, guarantees a high level of customer satisfaction. Through honest and targeted education, we help society to understand and use the versatile benefits of hemp. At the same time, we work completely transparently and are in constant exchange with the authorities to further improve access to CBD oil and hemp products. The continuously growing customer base over the years confirms us on our path. Become part of the CANNEXOL cannhelp community! 

At cannhelpwe take product safety very seriously. Therefore, we have our raw materials, but also our products, regularly tested by certified laboratories and also publish the results of these analyses and laboratory results in the Quality and Quality Assurance section on our homepage. 

Unsere CANNEXOL Produkte werden ausschließlich aus EU-zertifizierten Nutzhanfsorten gewonnen. Die Nutzhanfsorten sind im EU-Sortenregister freigegeben und enthalten nur geringe Spuren von Tetrahydrocannabinol (THC < 0,2%). Die Sorten unterliegen somit nicht dem Suchtmittelgesetz. Eine Verwendung von CBD Extrakten in Aromaölen ist erlaubt, solange es aus zertifiziertem Nutzhanf gewonnen wurde und auch während der Produktion die Grenze von 0.3% Tetrahydrocannabinol (THC) nicht übersteigt, da der Missbrauch als Suchtmittel somit ausgeschlossen werden kann.
Quelle 

Products to which CBD has been added are currently not yet approved for ingestion, since an approval at EU level is the prerequisite for marketing. The reason for this is the so-called "Novel Food Regulation", which states that foods that were not consumed to a significant extent before May 15, 1997 are first subject to a safety assessment by the European health authority EFSA and require approval.

This does not apply to foods that already contain natural levels of CBD such as hemp seed oil, hemp tea or hemp protein powder.
Source

The recent decisions of the United Nations (UN) to remove cannabis from Schedule IV of the 1961 Convention and to no longer classify it as a dangerous drug in the future is based, among other things, on the recommendation of the World Health Organization (WHO), and is intended to help recognize the medicinal value of cannabis. In parallel, the EU Commission has already confirmed in writing to the EIHA (European Industrial Hemp Association) in December 2020 that CBD can be classified as a possible food and not as a narcotic. The European Commission is resuming the review of applications for authorisation of CBD products and continuing those for applications already submitted. Daniel Kruse, president of the European Industrial Hemp Association called the development groundbreaking for the industry and was pleased with the decision to qualify CBD as a food rather than a drug.
Source

It is a pleasure for cannhelp, together with other European industry leaders, to be an active member of the EIHA Novel Food Consortium in taking this issue forward at this level. Again, we are fully transparent and in constant exchange with the authorities to further improve access to CBD oil and hemp products in the EU.

A medicinal effect may only be attributed to approved medicinal products, as the effect and safety have been verified by studies. Already approved medicines with CBD are used for epilepsy and multiple sclerosis because CBD has an anti-inflammatory and antispasmodic effect. However, this does not mean that all products with CBD have these effects and alleviate diseases.

Some manufacturers of food supplements with CBD advertise medical effects such as pain relief, reduction of anxiety or a general improvement in health, although their products have not been approved for this purpose.

cannhelpdoes not advertise any medicinal effects and does not give any recommendation regarding dosage and intake, as the products are aromatic oils.
Source

The endocannabinoid system (ECS), a complex physiological system, was first described in 1992 by a research team from the National Institute of Mental Health (NIMH, Bethesda, Maryland/USA) led by William Devane and Dr. Lumir Hanus in collaboration with the Israeli scientist Raphael Mechoulam. The ECS is an endogenous regulatory system of the nervous and immune system that can significantly influence the functions of memory, appetite, metabolism, temperature regulation, stress behaviour, immune response, pain perception and motivation. This happens through the production of endocannabinoids, such as anandamide and 2-AG, which can then bind to the receptors to have a regulating effect. CBD, among other plant substances, can also bind to these receptors and is therefore also called a phyto-cannabinoid.
In research, there is justified hope that targeted interventions in the body's own endocannabinoid metabolism will open up new therapeutic approaches. But more research is needed for this. 

Yes, we recommend the following books ....

Cannabis - Prescription help for doctors
by Grotenhermen / Häußermann

Cannabidiol, CBD - A natural healer of hemp
by Iris Pleyer, Michael Hlatky and Philipp Hlatky

Healing with CBD
by Leonard Leinow and Juliana Birnbaum

Cannabis Medicine: A Practical Guide for Patients andUsers
by Kurt Blaas

The healing power of CBD and cannabis
How we can improve our health with hemp products
by Franjo Grotenhermen